Mankind Pharma Ltd Sees 12.63% Surge in Open Interest Amid Price Decline

Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable increase in open interest today. The latest open interest stands at 15,207 contracts, reflecting a rise of 1,705 contracts or 12.63% from the previous open interest of 13,502. This uptick comes alongside a trading volume of 14,085 contracts, indicating active participation in the market. Despite this increase in open interest, Mankind Pharma's stock has underperformed relative to its sector, showing a decline of 1.81% today. The stock opened lower, down 2.56%, and reached an intraday low of Rs 2,248.6, marking a decrease of 2.62%. Over the past three days, the stock has faced consecutive losses, totaling a decline of 5.48%. In terms of liquidity, Mankind Pharma remains accessible for trading, with a delivery volume of 312,000 shares on November 6, which is 42.69% higher than its five-day average. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, reflecting a challenging market position. Overall, the increase in open interest amidst declining stock performance highlights a complex scenario for Mankind Pharma.